1.
Verbeeck RK, Niet SD, Lebrun S, Tremege M, Rennie TW, Coffiner M, et al. The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions. J Pharm Pharm Sci [Internet]. 2015 Feb. 3 [cited 2025 Apr. 2];18(1):61-7. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/23214